Arpeeneh Adamian is the Senior Director of Tax at Greenphire, the global leader in financial lifecycle management solutions for clinical trials. With over 15 years of experience in corporate taxation, international tax strategy, and regulatory compliance, Arpeeneh brings deep expertise at the intersection of financial operations and clinical research.
In her role at Greenphire, Arpeeneh manages all aspects of corporate tax and plays a pivotal role in shaping tax-compliant payment solutions for global clinical trial participants and sites. Her leadership extends to navigating complex tax regulations across multiple jurisdictions, ensuring both business and patient reimbursement processes meet evolving compliance standards.
Passionate about improving financial equity in clinical trials, Arpeeneh actively collaborates with research sites, sponsors, and CROs to identify tax barriers that impact participant payments—especially in oncology trials where out-of-pocket costs can be a deterrent to enrollment. Her insights help stakeholders develop innovative, patient-centric reimbursement solutions that remove financial obstacles and broaden trial access for underrepresented populations.
Prior to Greenphire, Arpeeneh held tax leadership roles at BDO, Baker Tilly, and Booz Allen Hamilton, advising companies on tax planning, financial reporting, and cross-border compliance. She is a Certified Public Accountant and holds a Master of Accountancy from the University of Denver.
Arpeeneh is a champion for operational efficiency, patient-centered financial strategies, and diversity in clinical research, making her a valuable voice in advancing equitable access to oncology trials.